BIOLASE Inc (NASDAQ:BIOL)
| 3.88 Data as of Jun 19 |  -0.10 / -2.51%Today’s Change | 1.47 Today|||52-Week Range 6.02 | +111.83% Year-to-Date |
Latest BIOL News | Press Releases
| Not Your Typical Set Up May 22 / StockTwits |
Today’s Trading
| Previous close | 3.98 |
| Today’s open | 4.01 |
| Day’s range | -- - -- |
| Volume | 374,147 |
| Average volume (3 months) | 462,514 |
| Market cap | $126.3M |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +32.01% |
| Earnings growth (this year) | +49.75% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +17.39% |
| P/E ratio | NM |
| Price/Sales | 1.01 |
| Price/Book | 10.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PDEXPro-Dex Inc | +0.01 | +0.53% |
| REMIRemedent Inc | 0.00 | 0.00% |
| ALGNAlign Technology Inc | -0.15 | -0.41% |
| SIROSirona Dental System... | -0.39 | -0.60% |
Data as of 4:00pm ET, 06/19/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $57.4M |
| Annual profit (last year) | -$3.1M |
| Net profit margin | -5.33% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Federico Pignatelli |
President, Chief Operating Officer & Director Alexander K. Arrow, MD, CFA |
Corporate headquarters Irvine, California |
Forecasts
